Uterine Fibroid Research Database
SB 196 establishes a uterine fibroid research database in Florida, improving data collection to enhance treatment options and awareness for women affected by fibroids.
SB 196 establishes a uterine fibroid research database in Florida, improving data collection to enhance treatment options and awareness for women affected by fibroids.
Bill Number: SB 196
Introduced: October 15, 2025
Status: Referred to Health Policy; Appropriations Committee on Health and Human Services; Fiscal Policy
Primary Sponsor: Senator Sharief
Effective Date: July 1, 2026
SB 196 aims to enhance the understanding and research of uterine fibroids by establishing a dedicated research database. The bill seeks to include uterine fibroids in the Florida Department of Health's list of diseases, thereby facilitating better data collection and analysis related to this common health issue affecting many women.
Inclusion of Uterine Fibroids: The bill mandates that the Florida Department of Health include uterine fibroids in the list of diseases as specified under section 381.0031(4) of the Florida Statutes.
Database Specifications: The bill amends existing legislation to allow for the creation of a uterine fibroid research database. This database will collect relevant health data without including any personal identifying information of women diagnosed with or treated for uterine fibroids.
Removal of Prohibition: The bill removes a previous prohibition on including certain data in the database, which may enhance the quality and scope of research conducted on uterine fibroids.
Affected Population: The primary beneficiaries of this legislation will be women diagnosed with uterine fibroids, healthcare providers, and researchers. By improving data collection, the bill aims to support better treatment options and awareness regarding uterine fibroids.
Research and Awareness: The establishment of this database is expected to lead to increased research opportunities, which could ultimately improve public health outcomes related to uterine fibroids.
Legislative Journey: After being filed on October 15, 2025, SB 196 was referred to the Health Policy and Appropriations Committees on Health and Human Services, as well as the Fiscal Policy Committee for further consideration.
Effective Date: If passed, the provisions of this bill will take effect on July 1, 2026.
This summary provides an overview of SB 196, highlighting its purpose, key provisions, potential impacts, and procedural status, making it accessible for both experts and general readers interested in legislative developments regarding women's health issues.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.